2025 Summit on Innovations in Controlled Release, Bioavailability Enhanceme

With about 20 worldwide approvals and almost a decade of commercial applications, CM is fertile ground for the next generation of implementation. Progress in the next few years will be fueled by major competitive advantages of CM:
- The faster speed in development of new products and processes enabled by CM will make it a central technology in pharmaceutical reshoring.
- The greater ability to model and control CM processes and improve quality control provides a major opportunity for the implementation of advanced manufacturing methodologies aligning closely with the FDA AMT designation program, enabling faster review of NDAs, ANDAs, and PAS.
- New formulation methods for continuous direct compression enable major reductions in the effort and materials required to develop or transfer manufacturing processes